This prompted the authors to propose that visfatin acts as a possible pro-inflammatory cytokine in women with PCOS, which may then explain how visfatin contributes to endothelial dysfunction in PCOS [116]. This evidence concerns the gene NAMPT and polycystic ovary syndrome.